EA Forum Podcast (All audio) “Introducing Access to Medicines Initiative: Year One Results, Year Two Strategy, and Current Funding Gap” by Miri, Evan LaForge
TL;DR
Exactly one year after receiving our seed funding upon completion of the Charity Entrepreneurship program, we (Miri and Evan) look back on our first year of operations, discuss our plans for the future, and launch our fundraising for our Year 2 budget.
Family Planning could be one of the most cost-effective public health interventions available. Reducing unintended pregnancies lowers maternal mortality, decreases rates of unsafe abortions, and reduces maternal morbidity. Increasing the interval between births lowers under-five mortality. Allowing women to control their reproductive health leads to improved education and a significant increase in their income. Many excellent organisations have laid out the case for Family Planning, most recently GiveWell.[1]
In many low and middle income countries, many women who want to delay or prevent their next pregnancy can not access contraceptives due to poor supply chains and high costs. Access to Medicines Initiative (AMI) was incubated by [...]
---
Outline:
(00:15) TL;DR
(01:28) The Problem
(03:30) Year 1 Retrospective
(03:34) Pilot
(07:19) Preliminary Pilot Results
(07:23) Increasing the Total Amount of Contraceptives
(09:57) Investigating the Distribution of Contraceptives
(11:37) Year 1 Spending
(12:44) Updated Cost-Effectiveness Analysis at Scale
(15:59) Our Strategy for Year Two (And Beyond)
(17:00) Expanding Our Procurement of Contraceptives
(18:21) Providing Technical Assistance for State-Funded Procurement of Contraceptives
(20:12) Improving and Expanding our Monitoring & Evaluation
(21:53) Projected Cost-Effectiveness of Our Year 2 Work
(22:38) Budget and Funding Gap
(24:00) Why Support Access to Medicines Initiative?
(26:50) How You Can Help
(27:50) Acknowledgments
The original text contained 7 footnotes which were omitted from this narration.
---
First published:
April 17th, 2025
---
Narrated by TYPE III AUDIO.